NCT06234514CompletedPhase 4
Manage Macular Cystoid Edema With Retinal Vein Obstruction Using Traditional Chinese Medicine and Ranibizumab
Traditional Chinese Medicine and Ranibizumab in the Treatment of Macular Cystoid Edema Associated With Retinal Vein Obstruction.
Source: ClinicalTrials.gov · Last updated 22 Aug 2025
Brief summary (registry, in English)
The objective of this study was to investigate the efficacy and safety of traditional Chinese medicine (Jueling Mingmu Decoction) combined with ranibizumab in the treatment of macular edema with retinal vein obstructive.
- Status (registry)
- Completed
- Phase (registry)
- Phase 4
- Study type
- Interventional
- Enrollment
- 111 (actual)
- First submitted
- 21 Jan 2024
- Start date
- 1 Jan 2023
- Primary completion date
- 31 May 2025
- Lead sponsor
- Dongyang People's Hospital
- NCT number
- NCT06234514
What you commit to
- Study type: Interventional · Phase 4
- Participants enrolled: 111
- From 1 Jan 2023 to the primary completion date, 31 May 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Concurrent serious conditions, such as cardiovascular diseases, liver, or kidney diseases
Other illness
- Known allergies to the ingredients of the medication.
Age
- Presence of any additional macular pathology, such as age-related macular degeneration (AMD) or diabetic retinopathy (DR) affecting the macula
Other
- Concerns or doubts regarding treatment
Who the study is looking for
- Foveal center-involved macular edema (ME) lasting less than 9 months
- Central Macular Thickness (CMT) greater than or equal to 250 μm
- Best-Corrected Visual Acuity (BCVA) of 24-73 letters (20/40 to 20/320) in the study eye
- Initial diagnosis with no prior treatments, such as laser therapy or intravitreal injections
Age in the registry: 18 years to - · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Dongyang People's Hospital Coordinator of this site? Confirm its status | Dongyang | China | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.